November 5, 2025 - 10:59

In a recent discussion, S.L. Erikson raised critical concerns regarding the financialization of the global health industry, emphasizing that this trend often translates to prioritizing profit over patient care. The increasing involvement of financial entities in healthcare sectors can lead to a focus on generating revenue rather than improving health outcomes. Erikson warns that when financial motives take precedence, the quality of care may suffer as healthcare providers are pressured to meet profit margins.
The implications of this shift are profound, as it can result in inflated costs for patients and reduced access to essential services. Erikson argues that stakeholders must remain vigilant and advocate for a healthcare system that prioritizes the well-being of individuals rather than the financial interests of corporations. As the landscape of global health continues to evolve, it is crucial to recognize the potential dangers of allowing profit-driven motives to dictate healthcare practices. The call to action is clear: prioritize health over wealth.
May 9, 2026 - 22:43
College of Pharmacy & Health Sciences confers 206 degrees - NewsThe Campbell University College of Pharmacy & Health Sciences held its spring commencement ceremony to honor the achievements of the Class of 2026. A total of 206 degrees were conferred during the...
May 9, 2026 - 02:40
California Becomes First State to Offer Free Diapers for Every NewbornCalifornia is set to launch a first-of-its-kind program that will provide free diapers to every newborn in the state. The initiative, which makes California the first state in the country to offer...
May 8, 2026 - 11:45
Maryland ranked high among states for public health preparedness, but could be doing moreMaryland continues to rank among the top states in the nation for its ability to handle public health emergencies, according to a recent analysis by a national health policy organization. The state...
May 7, 2026 - 18:47
Healthy Returns: First Ozempic generics in Canada will be a test case for Novo NordiskThe arrival of the first generic versions of semaglutide in Canada is being watched closely as a potential turning point for Novo Nordisk`s dominance in the global weight-loss and diabetes market....